Join Erick Siegenthaler, Senior Director of Infusion Strategy, as he discusses why an organization would partner with Visante for infusion strategy.
#1: VISANTE | HOW SHOULD HOSPITALS AND HEALTH SYSTEMS BE THINKING OF THEIR OVERALL INFUSION STRATEGY?
#2: VISANTE | WHY WOULD AN ORGANIZATION PARTNER WITH VISANTE ON INFUSION STRATEGY?
#3: VISANTE | WHAT ARE THE BIGGEST CHALLENGES FACED BY HOSPITALS OR HEALTH SYSTEMS WANTING TO ENTER OR EXPAND INFUSION?
#4: VISANTE | WHY SHOULD HOSPITALS AND HEALTH SYSTEMS CONSIDER AN INFUSION PROGRAM TODAY?
#5: VISANTE | WHY WOULD A COVERED ENTITY PARTNER WITH VISANTE FOR 340B ESP SUPPORT IF THEY HAVE INTERNAL RESOURCES?
#6: VISANTE | WHAT CHANGES HAVE YOU EXPERIENCED WHILE SUPPORTING COVERED ENTITIES DURING HRSA AUDITS?
#7: VISANTE | WHAT IS THE PROFILE OF A COVERED ENTITY THAT VISANTE SUPPORTS FOR ONGOING PROGRAM MANAGEMENT AND OVERSIGHT?
#8: VISANTE | WHAT DOES 340B PROGRAM MANAGEMENT AND OVERSIGHT SUPPORT CONSIST OF?
#9: VISANTE | WHY CHOOSE VISANTE FOR 340B?
#10: VISANTE | WHY SHOULD A HOSPITAL OR HEALTH SYSTEM PARTNER WITH VISANTE FOR 340B OPTIMIZATION?
#11: VISANTE | WHAT ARE SOME STRATEGIES THAT VISANTE USES TO HELP CLIENTS EXPAND THEIR 340B PROGRAM?
#12: VISANTE | HOW DOES VISANTE HELP CLIENTS OPTIMIZE THEIR MIXED-USE SPACE?
#13: VISANTE | AFTER IMPLEMENTATION, HOW CAN YOU OPTIMIZE YOUR SPECIALTY PHARMACY PROGRAM?
#14: VISANTE | WHAT ARE THE 5 KEYS TO SUCCESS WITH SPECIALTY PHARMACY?